These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 175359

  • 1. Selecting endocrine therapy for metastatic breast cancer.
    McGuire WL.
    Postgrad Med; 1976 Feb; 59(2):77-80. PubMed ID: 175359
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Hormone therapy and chemotherapy of cancer of the breast].
    Alberto P.
    Schweiz Med Wochenschr; 1969 Sep; 99(36):1287-96. PubMed ID: 5389128
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Hormonal management of advanced breast cancer.
    Stoll BA.
    Br Med J; 1969 May 03; 2(5652):293-7. PubMed ID: 5780457
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Prediction of breast cancer response to endocrine therapy.
    DeSombre ER, Smith S, Block GE, Ferguson DJ, Jensen EV.
    Cancer Chemother Rep; 1974 May 03; 58(4):513-9. PubMed ID: 4369030
    [No Abstract] [Full Text] [Related]

  • 9. Hormonal therapies in breast cancer.
    Kennedy BJ.
    Semin Oncol; 1974 Jun 03; 1(2):119-30. PubMed ID: 4620428
    [No Abstract] [Full Text] [Related]

  • 10. [Hormone-therapy of carcinoma of the breast].
    Villani C, Mazzon I.
    Minerva Ginecol; 1981 Jan 03; 33(1):3-26. PubMed ID: 7017505
    [No Abstract] [Full Text] [Related]

  • 11. [Behavior of hormonal patterns in breast neoplasms. Physiopathologic and clinical considerations].
    Giordano G, Cacciari P.
    Arch Sci Med (Torino); 1968 Oct 03; 125(10):525-35. PubMed ID: 5735716
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Hormonal therapy of metastizing breast cancer].
    von Werder K.
    Med Klin; 1976 Feb 20; 71(8):313-21. PubMed ID: 56699
    [No Abstract] [Full Text] [Related]

  • 14. Management of breast cancer.
    Cohen IA, Keller JH, Abate MA.
    Clin Pharm; 1982 Feb 20; 1(6):515-29. PubMed ID: 6192963
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Selecting endocrine therapy in breast cancer.
    McGuire WL, Horwitz KB, De La Garza M.
    Curr Top Mol Endocrinol; 1976 Feb 20; 4():28-35. PubMed ID: 1027543
    [No Abstract] [Full Text] [Related]

  • 17. Cancer of the breast: forward look in the 1970s. Endocrine therapy-the future.
    Hayward J.
    Proc R Soc Med; 1974 Apr 20; 67(4):290-2. PubMed ID: 4375822
    [No Abstract] [Full Text] [Related]

  • 18. [Possibilities and limitations of endocrine therapy of metastasizing breast cancer].
    Nowakowski H.
    Verh Dtsch Ges Inn Med; 1967 Apr 20; 73():505-18. PubMed ID: 5591802
    [No Abstract] [Full Text] [Related]

  • 19. [Endocrine and cytostatic therapy of metastasizing breast cancer in the female].
    Stolzenbach G, Nowakowski H.
    Dtsch Med Wochenschr; 1977 Oct 14; 102(41):1477-80. PubMed ID: 913282
    [No Abstract] [Full Text] [Related]

  • 20. [Chemo-hormonal therapy of carcinoma of the breast].
    Vertova F, Calza A.
    Radiol Med; 1970 Nov 14; 56(11):1067-79. PubMed ID: 4941205
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.